Finch Therapeutics Group Price on February 15, 2023

FNCHDelisted Stock  USD 8.51  0.19  2.18%   
If you're considering investing in Finch Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Finch Therapeutics stands at 8.51, as last reported on the 24th of November, with the highest price reaching 8.80 and the lowest price hitting 8.51 during the day. We have found twenty-four technical indicators for Finch Therapeutics Group, which you can use to evaluate the volatility of the firm. Please confirm Finch Therapeutics' Standard Deviation of 7.46, variance of 55.65, and Mean Deviation of 4.29 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Finch Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FNCH
Based on monthly moving average Finch Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Finch Therapeutics by adding Finch Therapeutics to a well-diversified portfolio.

Related Headline

C4 Therapeutics Headline on 15th of February 2023

Filed transaction by C4 Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Finch Therapeutics Valuation on February 15, 2023

It is possible to determine the worth of Finch Therapeutics on a given historical date. On February 15, 2023 Finch was worth 0.45 at the beginning of the trading date compared to the closed value of 12.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Finch Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Finch Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Finch Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Finch Therapeutics' related companies.
 Open High Low Close Volume
  0.46    13.58    13.58    13.58    7,721  
02/15/2023
  0.45    12.63    12.63    12.63    7,960  
  0.42    12.15    12.15    12.15    16,641  
Backtest Finch Therapeutics  |  Finch Therapeutics History  |  Finch Therapeutics Valuation   PreviousNext  
Open Value
0.45
12.63
Closing Value
0.45
Upside

Finch Therapeutics Trading Date Momentum on February 15, 2023

On February 16 2023 Finch Therapeutics Group was traded for  12.15  at the closing time. The top price for the day was 12.15  and the lowest listed price was  12.15 . The trading volume for the day was 16.6 K. The trading history from February 16, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.80% . The overall trading delta against the current closing price is 97.15% .

Finch Therapeutics Fundamentals Correlations and Trends

By evaluating Finch Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Finch Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Finch financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Finch Therapeutics Pink Sheet history

Finch Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Finch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Finch Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Finch Therapeutics stock prices may prove useful in developing a viable investing in Finch Therapeutics
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Finch Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.

Finch Therapeutics Pink Sheet Technical Analysis

Finch Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Finch Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Finch Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Finch Therapeutics Period Price Range

Low
November 24, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Finch Therapeutics Group cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Finch Therapeutics November 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Finch Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Finch Therapeutics shares will generate the highest return on investment. By undertsting and applying Finch Therapeutics pink sheet market strength indicators, traders can identify Finch Therapeutics Group entry and exit signals to maximize returns

Finch Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Finch Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Finch Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Finch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Finch Pink Sheet

If you are still planning to invest in Finch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Finch Therapeutics' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Valuation
Check real value of public entities based on technical and fundamental data